Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.
<label>PURPOSE</label>We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.<label>PATIENTS AND METHODS</label>In all, 559 patients with pancreatic cancer from prospective biomarker studies from Denmark (n = 448)...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3694124?pdf=render |